… Epstein–Barr virus (EBV) 1 preferentially infects B lymphocytes through the binding of the
major viral … , however, by the cell type from which viral preparations are made: virions that are …

The Epstein–Barr virus (EBV) was discovered 36 years ago by electron microscopy of cells
cultured from Burkitt's lymphoma tissue by Epstein, Achong, and Barr. Four years later, in …

… A promoter of Epstein-Barr virus that can function during latent infection can be transactivated
by EBNA-1, a viral protein required for viral DNA replication during latent infection. …

… Epstein–Barr virus is a tumorigenic herpes virus that is ubiquitous in the adult population. The
virus … More than 90% of the world's population carry Epstein–Barr virus as a life-long, latent …

… Epstein-Barr virus (EBV) infection of B cells causes them to become proliferating B blasts
due to expression of the viral growth transcription programme. The antigen-activated B blast …

… (restricted) equine abortion virus EBV nuclear antigen Epstein-Barr virus early membrane
antigen guinea pig herpesvirus herpes simplex virus herpesvirus ateles herpesvirus papio …

This review covers relevant clinical and laboratory information relating to Epstein-Barr virus (EBV)
infections in immunocompromised hosts. It describes the epidemiology and clinical …

… antibody against viral capsid antigen of Epstein-Barr virus and the … For Epstein–Barr nuclear
antigen, the relative risk was 4.0 (1.4 … by enhanced activation of Epstein–Barr virus. Whether …

The complete (172,282 base pairs) nucleotide sequence of the B95-8 strain of Epstein–Barr
virus has been established using the dideoxynucleotide/M13 sequencing procedure. Many …

Epstein–Barr virus (EBV), originally discovered through its association with Burkitt lymphoma,
is now aetiologically linked to a remarkably wide range of lymphoproliferative lesions and …